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Cytochrome P450 (CYP) 2E1 is an important enzyme involved in the metabolism
of many endogenous and exogenous compounds. It is essential to evaluate the
expression of CYP2E1 in the studies of drug–drug interactions and the screening of
drugs, natural products, and foodstuffs. The present work is a feasibility study on the
development of immunoassays using a specific and sensitive chicken-sourced anti-
CYP2E1 IgY antibody. Cloning, expression, and purification of a recombinant CYP2E1
(mice origin) protein were carried out. Anti-CYP2E1 IgY antibodies were generated
by immunizing white Leghorn chickens with purified recombinant CYP2E1 protein
and were purified by immune affinity chromatography. The IgY titer attained a peak
level (≥1:128,000) after the fifth booster injection. For evaluation of the expression
of CYP2E1 in different herbal treatment samples, the mice were treated by oral
gavage for 3 days with alcohol (50% 15 mL/kg), acetaminophen (APAP, 300 mg/kg),
Cornus officinalis extract (100 mg/kg), Alhagi-honey extract (100 mg/kg), Apocynum
venetum extract (100 mg/kg), hyperoside (50 mg/kg), isoquercetin (50 mg/kg), 4-
hydroxyphenylacetic acid (50 mg/kg), 3-hydroxyphenylacetic acid (50 mg/kg), and
3,4-hydroxyphenylacetic acid (50 mg/kg). The expression of CYP2E1 was determined
by Western blot analysis, immunohistochemistry, ELISA, and immunomagnetic beads
(IMBs) using anti-CYP2E1 IgY in liver tissue. The results showed that C. officinalis
extract, Alhagi-honey extract, A. venetum extract, hyperoside, isoquercetin, and
their xenobiotics 4-hydroxyphenylacetic acid, 3-hydroxyphenylacetic acid, and 3,4-
hydroxyphenylacetic acid significantly decreased CYP2E1 levels. Alcohol and APAP
treatments significantly increased CYP2E1 levels as analyzed with Western blot
analysis, immunohistochemistry, and ELISA. The IMB method is suitable for large-scale
screening, and it is a rapid screening (20 min) that uses a portable magnet and has
no professional requirements for the operator, which makes it useful for on-the-spot
analysis. Considering these results, the anti-CYP2E1 IgY could be applied as a novel
research tool in screening for the CYP2E1 inhibitor/enhancer.
Keywords: cytochrome P4502E1 (CYP2E1), chicken egg yolk antibody (IgY), falconoid, alcohol, APAP
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INTRODUCTION
Cytochrome P450 (CYP) 2E1 is one of the key enzymes in
the metabolism of numerous low molecular weight (<100 Da)
endogenous compounds and many xenobiotics. This enzyme is
highly induced by food or beverage constituents (alcohol), drugs
(acetaminophen) (Hartman et al., 2015), and pollutants (styrene).
CYP2E1 may eliminate potentially toxic compounds and,
paradoxically, bioactive compounds in toxins or carcinogens. For
example, CYP2E1 is induced during alcohol or acetaminophen
(APAP) overdose and results in the formation of ROS and
the increased generation of hydroxyl radicals (Jin et al.,
2013; Hartman et al., 2015). Increased oxidative stress from
induction of CYP2E1 can damage cellular and mitochondrial
components, including mitochondrial DNA and cytochrome
c oxidase (Demeilliers et al., 2002). An altered expression of
CYP2E1 can influence the disposition of drugs in the body,
causing altered plasma drug concentrations and leading to
adverse drug reactions or treatment failures. The evaluation of
CYP2E1 expression by different assays is the major focus of this
article.
Flavonoids, a wide group of natural products, have gained
considerable attention because of their low toxicity and powerful
biological activities against many ailments, such as liver disease,
cancer, reduced immune function, cardiovascular disease, and
hypoglycemia. Flavonoids are widely distributed in plants and
enter the human body through tea, vegetables, fruits, health care
products, herbal medicines, and other plant-derived products.
Apocynum venetum L., Alhagi-honey, and Fructus Corni are
popular herbs in traditional Chinese medicine and are rich in
flavonoids. Hyperoside and isoquercetin (Figure 1) are major
flavonoids significant for their hepatoprotective effects, but they
are poorly absorbed in the gastrointestinal tract (Chen et al.,
2005). After flavonoid administration, colonic bacteria convert
flavonoids into several simple phenolic acids – such as 4-
hydroxyphenylacetic acid, 3-hydroxyphenylacetic acid, and 3,4-
dihydroxybenzoic acid (Figure 1) (Yang et al., 2013) – that
can be absorbed into the circulation and exert biological effects
in the body. CYP2E1 are not only the metabolic enzymes
directly involved in hepatic oxidative damage, but they also
are important targets of the oxidation mechanism of liver
injury. Flavonoids have strong antioxidant and hepatoprotective
properties. Therefore, we speculated that flavonoids might
be active compounds that can reduce the impact of liver-
damaging substances by inhibiting the expression of CYP2E1,
which might be one of the hepatoprotective mechanisms of
flavonoids. Also, an investigation of the effects of flavonoids on
CYP2E1 expression is necessary since some daily foods (purple
potato, purple sweet potato, broccoli, bitter gourd, garlic, and
tomato), beverages (coffee and cacao polyphenol), and drugs
(Schisandra chinensis, danshen, Gelsemium elegans, isoniazid,
diallyl sulfide, sulforaphane, and tamoxifen) are metabolized by
CYP2E1 (Vang et al., 1991; Gu et al., 1992; Wargovich, 2006;
Wang et al., 2010, 2015; Konstandi et al., 2013; Su et al., 2013;
Ahmad et al., 2014; Lu et al., 2014; Zhou et al., 2014, 2015;
Shayakhmetova et al., 2015; Suzuki et al., 2015; Jiang et al.,
2016a,b).
The way to evaluate the influence of CYP2E1 on drug
interactions is to examine the activity and protein expression of
CYP2E1. The most common assay to test the activity of CYP2E1
is a PK-based method, such as HPLC (Martinez-Gil et al., 2015)
and HPLC-MS/MS (Liang and Zheng, 2014). While these assays
are effective in determining the activity of CYP2E1, they require
substrates and costly instruments. Another method to test the
expression of CYP2E1 is Western blotting. This assay, however,
is a time-consuming (more than 6.5 h), complicated operation
with many steps, expensive instruments, and no high-throughput
screening. This article focuses on the development of a fast,
sensitive, convenient, and immuno-based method to determine
the expression of CYP2E1.
IgY is the major serum antibody in avians, amphibians, and
reptiles. The significant advantage of using IgY antibodies
is that egg collection is non-invasive compared to the
stressful bleeding of animals to obtain serum. Also, the
absence of immunological cross-reactivity between chicken
IgY and mammalian IgG reinforces the advantages of
using IgY over IgG as the antibody of choice in some
types of immunological reactions (Larsson et al., 1993). For
instance, in immunochemical analysis, cross-reactions are
commonly observed between tissue IgG and epitopes shared
by the primary antibody and recognized by the secondary
mammalian antibody. This cross-reactivity is not observed
when IgY is used as the secondary antibody (Dias da Silva
and Tambourgi, 2010). Therefore, the aim of the present
study is to develop an immunoassay to determine CYP2E1
expression in mammals. An anti-CYP2E1 antibody can be
applied as an efficient research tool alternative to mammalian
sourced antibodies. This study also focuses on investigating
flavonoids and their secondary metabolites that may affect
CYP2E1 expression and cause medicine/food-medicine
interactions.
MATERIALS AND METHODS
Cloning and Expression of CYP2E1
Total mRNA was extracted from a mouse liver using an
RNAsimple Total RNA Kit (Tiangen Biotech, Beijing, China).
The CYP2E1 gene was amplified using primers P-Forward
(CGGGATCCGTTCTTGGCATCACCGTTGC) and P-Reverse
(CCCAAGCTTCTATTGTAACAGGGCTGAGGTCG). The tar-
get gene was subcloned into a pET-32 vector according to
NCBI sequence information (NM_021282.2), and the resulting
plasmids were transformed into E. coli BL21. Individual colonies
were selected and inoculated into 2YT broth that contained
ampicillin, and were subsequently incubated overnight at 37◦C.
After OD 600 reached 0.6, IPTG was added, and the cultures
were incubated for 10 h at 20◦C to induce expression of CYP2E1.
The pellets and supernatants were used to analyze the protein
solubility by SDS-PAGE. The inclusion bodies were predicated by
50 mM Tris-HCl (pH 8.0) containing 3% SDS and 1 mM EDTA.
The supernatant was collected by centrifugation at 12,000 rpm
and added to 50 mM Tris-HCl (pH 8.0) containing 0.15 M NaCl,
1 mM EDTA, 5% glycerol, and 200 mM urea for 24 h. The protein
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FIGURE 1 | The structures of flavonoids and their metabolites. (A) Flavonoid skeleton; (B) hyperoside; (C) isoquercitrin; (D) 3,4-dihydroxy-phenylacetic acid;
(E) 4-dihydroxy-phenylacetic acid; and (F) 3-dihydroxy-phenylacetic.
was dialyzed against PBS for 2 days at 4◦C. The purified protein
was assessed by SDS-PAGE.
Preparation of Anti-CYP2E1 IgY
Chicken Immunization
Seven-week-old white Leghorn chickens were first immunized
with 250 µg of CYP2E1 protein with Freund’s complete
adjuvant (FCA; Sigma-Aldrich Co., St. Louis, MO, USA). Three
boosters with Freund’s incomplete adjuvant were injected at 2-
week intervals, and the last booster with Freund’s incomplete
adjuvant was injected at a 30-day interval. After the first booster
immunization, eggs were collected daily, marked, and stored
at 4◦C until further processing. This study was carried out in
accordance with the recommendations of Li et al. (2016), Ethics
Committee of Northwest A&F University, the Guide for the Care
and Use of Laboratory Animals.
Total IgY was extracted using PEG 6000, as described in He
et al. (2015). In brief, each egg yolk was separated and diluted 1:2
with PBS (pH 7.4). To remove the lipids and lipoprotein, 3.5%
PEG 6000 was added to the yolk. After 13,000 g centrifugation
at 4◦C for 20 min, the suspensions were filtered and 8.5% PEG
6000 was added for 30 min. The mixtures were centrifuged again
at 13,000 g and 4◦C for 20 min. The precipitate was dissolved in
10 mL PBS with 12% PEG 6000. The mixtures were centrifuged
again in the same conditions as above. Finally, the precipitate
(IgY extract) was dissolved in 1.2 mL PBS. The extract was
contained in the dialysis capsule, dialyzed with PBS (1,000 mL),
and gently stirred using a magnetic stirrer for 3 days at 4◦C. The
PBS was changed every 8 h.
Immunoaffinity chromatography was used to purify the anti-
CYP2E1 antibodies. Purified recombinant CYP2E1 protein was
subjected to SDS-PAGE under reducing conditions on 12%
(80 V) and 5% gels (120 V). Separated proteins were then
transferred to PVDF membranes (120 mA, 40 min). After using
5% milk as a blocking agent for 1 h, the PVDF membranes
were incubated with the isolated anti-CYP2E1 IgY antibodies
(1:1,000) on the orbital shaker for 2 h. Next the membranes
were incubated with 1 mL Tris-HCl (pH 2.0) for 20 min, and
then the same volume of Tris-HCl (pH 8.0) was added for
neutralization. The purity of the anti-CYP2E1 IgY was then tested
by SDS-PAGE.
Monitoring of the IgY Titer
Indirect ELISA was used to determine the titer of the
specific antibody as described (He et al., 2015). The optimal
concentration of the agent was selected by the checkerboard
method. Western blotting was employed to determine the
purity and specificity of anti-CYP2E1 IgY; the protein was
separated using 12% SDS-PAGE and transferred onto a
PVDF membrane. The unreacted sites were blocked with
5% nonfat milk for 2 h at 37◦C, then incubated with anti-
CYP2E1-IgY (1:1,000) for 2 h and with an HRP-conjugated
goat anti-chicken antibody (1:10,000; Sigma, MO, USA)
for 1 h. The signal was visualized using ECL reagents from
the ChemiDoc Imaging System (Tanon 3500, Shanghai,
China).
Flavonoid Extraction
Each 10 g of Alhagi-honey and Corni fructus (Sieb. Et Zucc) and
50 g of dried leaves of A. venetum L. were extracted twice with
300 mL of 70% ethanol in a refluxed condenser for 1 h each. The
final volume was 100 mL of ethanol. The extracts were frozen,
lyophilized to dryness (Alhagi-honey 2.7 g, C. fructus 3 g, and
A. venetum L. 2.5 g), and stored at 4◦C until the analyses.
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Total Flavonoid Assay
The total flavonoid content was measured based on a previously
described method (HaiYing et al., 2009). Briefly, 0.5 mL of extract,
0.3 mL of 5% Na2NO2, and 0.3 mL of 10% AlCl3-methanol
solution were mixed in a 10 mL test tube. After 6 min, 2 mL
NaOH (1 M) solution was added, and then the mixture was
eventually added to 10 mL of 50% v/v methanol. The absorption
value was measured using a spectrophotometer at 510 nm.
A standard curve for total flavonoids was prepared using rutin
(0, 2.5, 5, 10, 20, 40, 80, and 120 mg/g), and the total flavonoid
content was expressed as milligrams of rutin equivalents per gram
of dried extract.
Animal Treatments
A total of 4-week-old Kunming female and male mice were
purchased from the animal center of the Fourth Military Medical
University, Xi’an, China. The mice had access to drinking
water and food and were housed at room temperature with
an automatic 12 h light and 12 h dark cycle. All animal
experiment protocols were reviewed and approved by the
Ethics Committee of Northwest A&F University for the use of
Laboratory Animals.
After a 1-week acclimation, the mice were randomly divided
into 11 groups, seven in each group. All the treatment groups
were treated by oral gavage for 3 days as per the experimental
design. The 11 groups were: a normal group (normal saline
10 mL/kg), APAP group (APAP 300 mg/kg), alcohol group (50%
15 mL/kg), Cornus officinalis group (100 mg/kg extraction),
Alhagi-honey group (100 mg/kg extraction), A. venetum group
(100 mg/kg), hyperoside group (50 mg/kg), isoquercetin
group (50 mg/kg), 4-hydroxyphenylacetic acid group
(50 mg/kg), 3-hydroxyphenylacetic acid group, (50 mg/kg),
and 3,4-hydroxyphenylacetic acid group (50 mg/kg extraction).
The mice were sacrificed with diethyl ether 24 h after the last
administration. Their livers were immediately removed. One part
of the liver was fixed with 4% paraformaldehyde; the other part
was washed in ice-cold saline and frozen at −20◦C for further
study.
Western Blot Analysis of CYP2E1 Protein
Expression
Liver microsomal protein preparation was carried out per the
previous study by Jiang et al. (2016a). After determining the
protein concentration using the Bradford protein assay (Tiangen
Biotech, Beijing, China), protein samples (80 µg) were run
on a 12% and 5% SDS-PAGE gel and transferred onto PVDF
membranes. After blocking, the membranes were incubated with
anti-CYP2E1 IgY antibodies (1:1,000) and mouse polyclonal
anti-GAPDH antibodies (1:1,000; Wuhan Boster Biological
Technology, Wuhan, China) for 2 h. The membrane was washed
three times with TBST and incubated with an HRP-conjugated
rabbit anti-chicken IgY antibody (1:10,000, Sigma, USA) or a
goat anti-mice IgG antibody (1:10,000; Wuhan Boster Biological
Technology, Wuhan, China) for 2 h. The signal was visualized
using the ChemiDoc Imaging System (Tanon 3500, Shanghai,
China).
Indirect ELISA Determination of CYP2E1
Protein Expression
Indirect ELISA was used to detect the expression of CYP2E1 in
each treated sample. The total sample protein was coated onto
the 96-well plates overnight at 4◦C, and 5% non-fat milk was
used for blocking for 2 h at 37◦C. After washing three times
with PBS, the purified anti-CYP2E1 IgY antibody (1:1,000) and
the commercial anti-CYP2E1 IgG antibody were incubated for
2 h at 37◦C. After washing three times with PBST and one time
with PBS, the secondary goat anti-chicken IgG conjugated to
HRP (1:10,000, Sigma, USA) was added for 1.5 h at 37◦C. After
washing, TMB was added and incubated for 5 min in the dark at
room temperature, and the absorbance was read at 450 nm.
Immunohistochemistry Investigation on
CYP2E1 Location and Expression
The fixed mice liver tissue was embedded in paraffin and
sectioned at 5 µm thickness. The sections were incubated
with anti-CYP2E1 IgY antibody (1:800) for 1 h, then washed
three times using PBS and incubated with rabbit anti-chicken
secondary antibody (1:10,000, Sigma, USA) for 1 h. After the
sections were washed with PBS three times, the images were
captured using a digital camera.
Immunomagnetic Aggregation Sensor
Screening for CYP2E1 Protein
Expression
The immunomagnetic beads (IMBs) were employed as described
in Chen et al. (2016). Briefly, the amine IMBs (Emerther
Company, Shanghai, China) were activated by 5% glutaraldehyde
and a coupling buffer for 3 h. Subsequently, 0.1 mg anti-CYP2E1
IgY antibody was added to the activated IMB solution. The
mixture was gently stirred, to allow the reaction to proceed, for
24 h at room temperature and then blocked with 1% BSA for
0.5 h. The IMBs were suspended with washing buffer and stored
at 4◦C for further use.
To detect CYP2E1 expression, researchers transferred 300 µL
of the IMB solution and 1,200 µL of the microsomal protein
to centrifuge tubes. Each mixture was incubated for 20 min.
Then, all the tubes were put on a magnetic scaffold, the color
changes of the IMBs were observed after 1 min, and the images
were captured by a digital camera. The colors of the IMBs were
processed into grayscale values by ImageJ software (National
Institutes of Health, MD, USA).
To detect the specificity of immunomagnetic aggregation
(IMA) sensor, the protein in the magnetic beads were eluted with
1 mL Tris-HCl (pH 4.5) for 20 min, and then the same volume of
Tris-HCl (pH 8.0) was added for neutralization. The elution was
run on 12 and 5% SDS-PAGE gels and transferred onto PVDF
membranes. After blocking, the membranes were incubated
with anti-CYP2E1, CYP1A2, CYP2C9, CYP2D6, CYP2C19, and
CYP3A4 IgG antibodies (1:1,000; Bioss, Beijing, China) for 2 h.
The membrane was washed three times with TBST and incubated
with an HRP-conjugated rabbit anti-IgG antibody (1:2,000,
Senjian, Tianjing, China) for 2 h. The signal was visualized using
the ChemiDoc Imaging System.
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Data Analysis and Statistical Methods
The data were analyzed using SPSS 19 software (SPSS Inc.,
Chicago, IL, USA). A one-way ANOVA was employed for
comparison among the groups, and Tukey’s comparison tests of
significant differences among groups were utilized. The results
were expressed as mean ± standard deviation (SD) using Graph
Pad Prism Software v.7 (GraphPad Software, Inc., San Diego, CA,
USA).
RESULTS
CYP2E1 Gene Amplification and
Anti-CYP2E1 IgY Antibody Purification
The total of mRNA in mice liver was extracted, the cDNA
fragment of the CYP2E1 gene was PCR-amplified by PCR,
and the 1,481 bp product (Figure 2A) was cloned into the
recombinant expression vector pHT-32a-CYP2E1, which was
then transformed into E. coli BL21 to express the CYP2E1
protein.
After PEG 6000 extraction, the IgY light chain, heavy
chain, and some lower molecular weight bands were observed
in SDS-PAGE under reducing conditions (Figure 2B). The
lower molecular weight bands were removed by immunoaffinity
chromatography (Figure 2C).
Titer and Binding Activity of Anti-CYP2E1
IgY
The titers of specific IgY were determined by indirect ELISA.
The IgY titer (1:25,600) was increased after the fourth booster
injection, reached a peak (1:128,000) after the fifth booster
injection, and was found to be stable at the highest titer for more
than 1 month. The titers gradually decreased to 1:25,600 and
remained at this level until the end of the experiment (Figure 3A).
The binding activity of IgY to CYP2E1 was further determined by
Western blot analysis. The isolated IgY was bound to the CYP2E1
protein at a dilution of 1:1,000 (Figure 3B). The commercial IgG
antibody was bound to three proteins at a dilution of 1:1,000
(Figure 3C).
Total Flavones of Herbal Extracts
The values of standard rutin showed an excellent linear relation,
y = 3.907x+0.0080 (R2 = 0.9991). The total flavone contents
of A. venetum L. extract, Alhagi-honey extract, and C. officinalis
extract were found to be 62.2 ± 0.8 mg/g, 41.3 ± 0.4 mg/g, and
52.1± 0.7 mg/g, respectively.
Western Blot and Immunohistochemistry
Determination of the Effect of Different
Flavone Treatments on CYP2E1
The protein expressions of CYP2E1 were significantly increased
in APAP- and alcohol-treated groups (Figures 4A,B), and the
ratios of protein expression of CYP2E1 in alcohol and APAP-
treated groups were 1.5- and 1.31-fold higher than that of the
control group. The expression of CYP2E1 in C. officinalis extract,
Alhagi-honey extract, and A. venetum L. extract was significantly
lower than that of the controls. The isoquercetin, hyperoside,
4-hydroxyphenylacetic acid, 3-hydroxyphenylacetic acid, and
3,4-hydroxyphenylacetic acid treatments significantly reduced
CYP2E1 expression, and the levels of CYP2E1 were the lowest
in the 3,4-hydroxyphenylacetic acid and 4-hydroxyphenylacetic
acid treatments among all the treatments. The location of
CYP2E1 expression was determined by immunohistochemistry.
As shown in Figure 5, CYP2E1 expression was located around
the central vein in the mouse liver and was induced by
alcohol and APAP treatments. Hyperoside, isoquercetin, and 3,4-
hydroxyphenylacetic acid significantly decreased the CYP2E1
expression.
ELISA Assessment on the Effect of
Different Flavone Treatments on CYP2E1
The hepatic expression of CYP2E1 in different treatments was
detected by direct ELISA with an anti-CYP2E1 IgY or IgG
antibody. Alcohol and APAP increased the levels of CYP2E1, as
shown in Figure 6, and the Alhagi-honey extract, A. venetum
extract, isoquercetin, hyperoside, 4-hydroxyphenylacetic acid,
3-hydroxyphenylacetic acid, and 3,4-hydroxyphenylacetic acid
significantly decreased the expression of CYP2E1. The expression
of CYP2E1 in the Cornus Alhagi-honey extract was significantly
decreased with control group as detected by the IgY antibody, and
Alhagi-honey extract treatment using an IgG antibody were not
significantly different compared with control group.
IMB Evaluation of the Effect of Different
Flavone Treatments on CYP2E1
Using IMA sensors, the color intensity changed from dark brown
to light yellow when the concentration of the IMBs changed from
1 to 10−5 mg/mL (Figure 7A). As shown in Figure 7B, IMBs in
samples 2 and 3 were heavily aggregated, samples 1, 4, and 6 were
gently aggregated, and the other samples were well-dispersed,
suggesting that the CYP2E1 protein expression was significantly
increased (p < 0.05) in APAP- and alcohol-induced groups.
The isoquercetin, hyperoside, 4-hydroxyphenylacetic acid, 3-
hydroxyphenylacetic acid, and 3,4-hydroxyphenylacetic acid
treatment significantly reduced CYP2E1 expression (Figure 7C),
and the trend of expression was consistent with the Western blot
and ELISA results. The cross-reactivity of the anti-CYP2E1 IgY
antibody with the anti-CYP1A2, CYP2C9, CYP2D6, CYP2C19,
and CYP3A4 antibodies was tested by Western blot. Results
indicated that the anti-CYP2E1 IgY antibody showed no cross-
reactivity with other proteins (CYP1A2, CYP2C9, CYP2D6,
CYP2C19, and CYP3A4), indicating that the anti-CYP2E1 IgY
antibody is highly specific for CYP2E1 (Figure 7D).
DISCUSSION
The CYP2E1 level is a key indicator in pharmacological and
toxicological screening. The classical assay to assess the CYP2E1
protein and activity is by PK-based HPLC and HPLC-MS/MS
analysis. While these assays are precise and sensitive methods for
CYP2E1 detection, CYP2E1-specific substrates and sophisticated
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FIGURE 2 | Cytochrome P4502E1 (CYP2E1) gene amplification and anti-CYP2E1 IgY antibody purification. (A) Lane M: marker, lane 1 and 2 are
amplification of CYP2E1; (B) lane M: marker, lane S: unpurified anti-CYP2E1 IgY antibody; and (C) lane M: marker, lane S: purified anti-CYP2E1 IgY antibody.
FIGURE 3 | Titer and binding activity of anti-CYP2E1 IgY. (A) Development of IgY titer against recombinant CYP2E1 protein; (B) lane 1 and 2, CYP2E1 protein
recognized by IgY; and (C) lane 1 and lane 2, CYP 2E1 protein recognized by commercial IgG polyclonal antibody.
instrumentation are required for analysis. In this study, we have
developed an alternative analysis immunochemical procedure
that is fast and sensitive for CYP2E1 screening. The anti-CYP2E1
antibody was successfully prepared, and the levels of hepatic
CYP2E1 expression in different flavonoid treatment groups, as
well as alcohol and APAP treatments, were evaluated by different
immunoassays.
The IMB assay is a novel biosensor assay that combines
magnetic separation and a visual readout in one step for the
determination of biomarkers (Chen et al., 2016). Quantification
of the protein being detected is dependent on the degree of
IMB aggregation, which is sample-concentration dependent.
Compared to other immunoassays, the IMB assay enables
readout by the naked eye (Chen et al., 2016). The aggregated
IMBs will present a brown color with a narrow stripe,
distinguishable from dispersed IMBs with a yellow coating.
In this study, the color change of IMBs could allow the
reader to distinguish concentrations of CYP2E1 ranging from
10−5 mg/mL to 1 mg/mL (Figure 7A). Results indicated that
the anti-CYP2E1 IgY antibody showed no cross-reactivity with
other proteins (CYP1A2, CYP2C9, CYP2D6, CYP2C19, and
CYP3A4), indicating that the anti-CYP2E1 IgY antibody is highly
specific for CYP2E1; however, the sensitivity of IMB is lower
than that for ELISA and Western blotting. Importantly, our
IMB tendency is consistent with those using Western blotting,
and this semi-quantity is sufficient for preliminary analysis of
Frontiers in Pharmacology | www.frontiersin.org 6 December 2016 | Volume 7 | Article 502
fphar-07-00502 December 21, 2016 Time: 17:46 # 7
Jiang et al. IgY Screening of the CYP2E1 Inhibitor/Enhancer
FIGURE 4 | Western blot analysis of CYP2E1 expression using CYP2E1 IgY. (A) Representative blots of CYP2E1 and GAPDH expression. lane 1, control
group; lane 2, APAP-treated group; lane 3, alcohol-treated group; lane 4, Cornus officinalis-treated group; lane 5, Alhagi-honey-treated group; lane 6, Apocynum
venetum-treated group; lane 7, hyperoside-treated group; lane 8, isoquercitrin-treated group; lane 9, 4-hydroxyphenylacetic-treated group; lane 10, control group;
lane 11, 3-hydroxyphenylacetic-treated group; lane 12, 3,4-hydroxyphenylacetic-treated group. (B) Relative quantification of CYP2E1 protein levels by Gel-Protein
analyzer soft. Each value represents the mean ± SD of three independent experiments. ∗P < 0.05 compared with the control group.
FIGURE 5 | Immunohistochemical detection of CYP2E1 expression. The mice livers were used for immunohistochemical detection. (A) control group; (B)
alcohol-treated group; (C) APAP-treated group; (D) hyperoside-treated group; (E) isoquercitrin-treated group; and (F), 3,4-hydroxyphenylacetic-treated group.
herbs and compounds. Compared to Western blotting, the IMB
method is suitable for large-scale screening, as it is a rapid
process (20 min) that applies a portable magnet and does not
require a professional for its operation. These features make
IMB suitable for on-the-spot analysis. Western blot and ELISA
are widely used methods for the immunological detection of
proteins. Compared to IgG antibodies, using anti-CYP2E1 IgY
antibodies creates a significant difference between each group
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FIGURE 6 | Relative expression of CYP2E1 in different treatments. (A) Using anti-CYP2E1 IgY antibody; (B) using anti-CYP2E1 IgG antibody. ∗P < 0.05
compared with the control group.
by ELISA (Figure 6). For example, the levels of CYP2E1 in
Alhagi-honey were significantly different from that of the control
using the anti-CYP2E1 IgY, while no significant difference
was observed using the anti-CYP2E1 IgG, suggesting the anti-
CYP2E1 IgY antibody has a good sensitivity and specificity.
However, these immunoassays are time-consuming and require
complex manipulation and expensive instrumentation. The IMB
assay is easily developed into a rapid assay, allowing a one-step
process that can be completed within 20 min. IMB is a low-
cost and portable diagnostic tool with magnetic beads and a
camera, thus meeting the needs of point-of-care-testing and high-
throughput screening. Furthermore, IMBs are stable after 24 h in
a magnetic field without affecting the results of the IMA sensor
(Chen et al., 2016).
Chickens are a good choice for the preparation of specific
antibodies with high titers developed against highly conserved
mammalian antigens due to the evolutionary distance between
the source of the antigen (mammals) and the immune system
(chickens) (Schade and Hlinak, 1995). Indeed, it has been widely
recognized that the absence of immunological cross-reactivity
between chicken IgY and mammalian IgG is determined by the
evolutionary divergence (Kovacs-Nolan and Mine, 2004). In this
study, the highest titer of 1:1,280,000 was observed after the
fifth booster injection, and it remained elevated for more than
1 month (Figure 3). IgY is easily produced with large yields of
approximately 100 mg IgY per egg yolk (Schade and Hlinak,
1995). A total of 84 eggs were collected with anti-CYP2E1 IgY
titers of more than 1:25,600 CYP2E1 per egg yolk following four
boosters. Western blotting revealed that the anti-CYP2E1 IgY
antibody could specifically recognize the CYP2E1 protein. The
anti-CYP2E1 IgY antibody showed a lower false positive rate than
that of a commercial antibody (Figures 3B,C). These findings
suggest that anti-CYP2E1 is a valuable research tool for exploring
the expression of the CYP2E1 protein.
An overdose of alcohol or APAP generates the first hit
on the liver, and the major metabolic enzyme CYP2E1 could
generate the second hit of cellular injury (Robertson et al.,
2001), particularly when antioxidant reserves are depleted. In
this study, higher levels of CYP2E1 expression were observed
after alcohol or APAP treatment by different immunoassays.
In contrast, C. officinalis extract, Alhagi-honey extract, and
A. venetum extract significantly decreased the expression of
CYP2E1. These three herbal medicines can protect the liver
against alcohol- or APAP-induced liver injuries in animal models
(Shaker et al., 2010; Nam et al., 2014; Xie et al., 2015), suggesting
that hepatocyte damage was effectively attenuated by C. officinalis
extract, Alhagi-honey extract, and A. venetum extract. To
further explore whether the major hepatoprotective effects of
flavonoids and their metabolites can inhibit the expression
of CYP2E1, hyperoside, isoquercetin, 4-hydroxyphenylacetic
acid, 3-hydroxyphenylacetic acid, and 3,4-hydroxyphenylacetic
acid were used to modify the expression of CYP2E1 as
determined by Western blot, immunohistochemistry, ELISA,
and IMB methods. Results showed that these five compounds
all inhibited the expression of CYP2E1, suggesting they may
protect the liver against alcohol- and APAP-induced injury.
The clinical dosages of drugs metabolized by human CYP2E1
might need to be adjusted in patients because these herbal
medications may increase the plasma concentrations of these
drugs.
CONCLUSION
In this study, a rapid IMB was developed to test the hepatic
expression of CYP2E1 following different flavonoid treatments.
This investigation formed the basis for a proof of concept for the
use of various applications of anti-CYP2E1 IgY as a screening tool
using different immunological methods. Also, the use of anti-
CYP2E1 IgY with IMA sensors could be applied as a fast and
useful research tool in the development and high-throughput
screening of CYP2E1 inhibitor/enhancer compounds by the
naked eye based on the color change of the IMBs. Furthermore,
this assay may serve as a valuable tool to provide an application
for the detection of clinical drug–drug interactions observed
during early or late drug development.
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FIGURE 7 | IMA sensor detection of CYP2E1 expression. (A) Different concentrations of CYP 2E; (B) the expression of CYP2E1 in different treatment samples.
1, control; 2, APAP; 3, alcohol; 4, isoquercitrin; 5, hyperoside; 6, 4-hydroxyphenylacetic; 7, 3-hydroxyphenylacetic; 8, 3,4-hydroxyphenylacetic; (C) relative
densitometry intensity of IMA sensor signal as assessed by ImageJ; (D) cross-reactivity of anti-CYP2E1 with various anti-CYP450 antibodies. ∗P < 0.05 and
∗∗P < 0.01 compared with the control group.
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